Le Lézard
Classified in: Health
Subject: SVY

Interventional Radiology Market (2014-2024)


NEW YORK, Nov. 14, 2019 /PRNewswire/ --

Interventional Radiology Market (2014-2024)

According to a study, the interventional radiology market is expected to reach $27.3 billion in terms of revenue generation by 2024, witnessing a CAGR of 6.4% during the forecast period. The key factors driving the market are increasing prevalence of chronic diseases, advancements in technology, growing aging population, and improving reimbursement rate for interventional radiology procedures.

Read the full report: https://www.reportlinker.com/p05760339/?utm_source=PRN

There are different types of products available in the interventional radiology market, including magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), angiography systems, and others. The market for ultrasound systems is estimated to progress substantially during the forecast period, registering a CAGR of 6.2%. The reason for such growth would be the increasing prevalence of birth disorders and chronic diseases that are boosting the demand for ultrasound systems globally.

Furthermore, the domain, on the basis of application, is categorized into cardiology, oncology, gastroenterology, urology and nephrology, obstetrics and gynecology, and others. Out of these, oncology is estimated to contribute the most significant share to the interventional radiology market in the forecast period. The oncology segment is expected to generate $5.1 billion revenue for the market in 2018 and $7.3 billion by 2024. Across the globe, the increasing prevalence of cancer has boosted this segment. Furthermore, the market for gastroenterology is also expected to experience significant growth, progressing at a CAGR of 5.9% during the analysis period.

On a global ground, North America is leading the interventional radiology market in 2018 with nearly 36.0% revenue share, and it is forecasted to contribute $9.3 billion revenue by 2024. The key factors driving the growth of the domain in the region are increasing healthcare expenditure and advanced healthcare facilities. During the analysis period, the market is predicted to grow the fastest in APAC, witnessing a CAGR of 7.9%, due to the increasing prevalence of chronic diseases, improving healthcare infrastructure, and rising geriatric population and healthcare expenditure.

Moreover, developing countries, such as China and India, are increasing their healthcare expenditure to improve the healthcare infrastructure, which is impelling companies to invest in the region by creating notable revenue generation opportunities. According to the World Bank, China's healthcare expenditure in 2005 was 4.3% of its GDP, which increased to 5.3% in 10 years.

Across the globe, the interventional radiology market is registering growth owing to a substantial number of new equipment being introduced by prominent players. For instance, Canon Medical Systems Corporation, within its Vitrea platform, launched the illumination rendering technology in January 2019. This will enable real-time interaction with photorealistic images, allowing physicians to visualize patient's anatomy in all dimensions. That same year, Canon also launched the Aquilian Start CT system in Dubai.

Interventional Radiology Market Segmentation
Market Segmentation by Product
- MRI Systems
- CT Systems
- Ultrasound Systems
- Angiography Systems
- Others

Market Segmentation by Procedure
- Angioplasty
- Biopsy and Drainage
- Embolization
- Catheter-Directed Thrombolysis
- Vertebroplasty
- Nephrostomy
- Others

Market Segmentation by Application
- Cardiology
- Oncology
- Urology and Nephrology
- Gastroenterology
- Obstetrics and Gynecology
- Others

Market Segmentation by End User
- Hospitals
- Ambulatory Surgical Centers (ASCs)

Market Segmentation by Geography
- North America Interventional Radiology Market

- By product
- By procedure
- By application
- By end user
- By country ? U.S. and Canada

- U.S. Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- Canada Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- Europe Interventional Radiology Market

- By product
- By procedure
- By application
- By end user
- By country ? Germany, France, U.K., Spain, Italy, and Rest of Europe

- Germany Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- France Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- U.K. Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- Spain Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- Italy Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- Asia-Pacific (APAC) Interventional Radiology Market

- By product
- By procedure
- By application
- By end user
- By country ? Japan, China, India, Australia, and Rest of APAC

- Japan Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- China Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- India Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- Australia Interventional Radiology Market

- By product
- By procedure
- By application
- By end user

- Latin America (LATAM) Interventional Radiology Market

- By product
- By procedure
- By application
- By end user
- By country ? Brazil, Mexico, and Rest of LATAM

- Brazil Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- Mexico Interventional Radiology Market

? By product
? By procedure
? By application
? By end user

- Middle East & Africa (MEA) Interventional Radiology Market

- By product
- By procedure
- By application
- By end user
- By country ? Saudi Arabia, South Africa, and Rest of MEA

Read the full report: https://www.reportlinker.com/p05760339/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 07:15
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the "Company" or "IPA") , InterSystems, a creative data technology provider dedicated to helping customers solve their most critical scalability, interoperability, and speed challenges, together with ImmunoPrecise...

at 07:10
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced financial results and clinical updates for the twelve months ended...

at 07:10
Kelonia Therapeutics, a biotech company revolutionizing in vivo gene delivery, today announced the appointments of global leaders in cell therapy and drug development, Kristen Hege, M.D., and Mathai Mammen, M.D., Ph.D., to its board of directors....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced the clinical development plan intended to enable...

at 07:05
Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate (ADC) therapies for the treatment of a wide range of cancers, announced that George Eliades, Ph.D., has joined the...

at 07:05
Seres Therapeutics, Inc. ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on March 25, 2024, the Compensation and Talent Committee of Seres' board of directors granted inducement equity grants covering an...



News published on and distributed by: